Bastiaans, K.Crowther, C.2006-06-242006-06-242003Australian and New Zealand Journal of Obstetrics and Gynaecology, 2003; 43(3):222-2250004-86661479-828Xhttp://hdl.handle.net/2440/7959The definitive version is available at www.blackwell-synergy.comBackground: The present study assessed the screening tests for Down syndrome available to women within Australian hospitals. Methods: Postal questionnaires. Results: A total of 282 (57%) hospitals responded with over two-thirds offering some form of screening test which varied by geographical region and level of institution. First trimester maternal serum screening was offered by 11% of hospitals. Nuchal translucency screening was offered by 52% of hospitals with higher use in Australian Capital Territory and New South Wales than in the other regions. Second trimester maternal serum screening was offered by 75% of hospitals with higher rates in Australian Capital Territory, South Australia and the lowest rate in Queensland. Conclusions: A high proportion of women are offered screening but with wide variation in the tests used.enDown syndromematernal serum screeningnuchal translucency screeningscreening testsJournal article002003057410.1046/j.0004-8666.2003.00071.x0001835757000092-s2.0-003781305958747Crowther, C. [0000-0002-9079-4451]